Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of MH004 ointment in adolescents and adults with non-segmental vitiligo
CTR20262503Phase 3Active
- Sponsor
- Minghui Pharmaceutical, Inc.
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tofacitinib etocomil in Vitiligo, sponsored by Minghui Pharmaceutical, Inc.. Started Jun 2026; status: active.
02
Drugs
tofacitinib etocomil
03
Conditions
Vitiligo
Beyond the preview
Go deeper on CTR20262503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262503.